Corcept Therapeutics (CORT) Shareholder's Equity Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.63% |
| Dec 31, 2025 | -4.68% |
| Sep 30, 2025 | -1.09% |
| Jun 30, 2025 | 6.63% |
| Mar 31, 2025 | 24.72% |
| Dec 31, 2024 | 34.12% |
| Sep 30, 2024 | 38.37% |
| Jun 30, 2024 | 41.42% |
| Mar 31, 2024 | 3.45% |
| Dec 31, 2023 | 0.97% |
| Sep 30, 2023 | -2.47% |
| Jun 30, 2023 | -4.68% |
| Mar 31, 2023 | 29.86% |
| Dec 31, 2022 | 33.54% |
| Sep 30, 2022 | -12.38% |
| Jun 30, 2022 | -15.37% |
| Mar 31, 2022 | -20.16% |
| Dec 31, 2021 | -28.19% |
| Sep 30, 2021 | 10.32% |
| Jun 30, 2021 | 15.20% |
| Mar 31, 2021 | 24.74% |
| Dec 31, 2020 | 40.99% |
| Sep 30, 2020 | 46.45% |
| Jun 30, 2020 | 52.22% |
| Mar 31, 2020 | 43.30% |
| Dec 31, 2019 | 34.54% |
| Sep 30, 2019 | 28.83% |
| Jun 30, 2019 | 22.40% |
| Mar 31, 2019 | 32.77% |
| Dec 31, 2018 | 44.47% |
| Sep 30, 2018 | 200.74% |
| Jun 30, 2018 | 268.14% |
| Mar 31, 2018 | 334.10% |
| Dec 31, 2017 | 361.51% |
| Sep 30, 2017 | 176.19% |
| Jun 30, 2017 | 157.77% |
| Mar 31, 2017 | 145.83% |
| Dec 31, 2016 | 123.69% |
| Sep 30, 2016 | 131.85% |
| Jun 30, 2016 | 122.63% |
| Mar 31, 2016 | 90.77% |
| Dec 31, 2015 | 645.99% |
| Sep 30, 2015 | 1,123.31% |
| Jun 30, 2015 | 233.89% |
| Mar 31, 2015 | 12.82% |
| Dec 31, 2014 | -116.12% |
| Sep 30, 2014 | -104.28% |
| Jun 30, 2014 | -91.45% |
| Mar 31, 2014 | -81.63% |
| Dec 31, 2013 | -65.98% |
| Sep 30, 2013 | -57.05% |
| Jun 30, 2013 | 23.07% |
| Mar 31, 2013 | 29.72% |
| Dec 31, 2012 | 77.48% |
| Sep 30, 2012 | 64.09% |
| Jun 30, 2012 | -32.87% |
| Dec 31, 2011 | 63.84% |